Investor Access Industries Holdings LLC
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Access Industries Holdings LLC . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-02-14 13G/A WMG / Warner Music Group Corp. 376,240,139 374,517,252
2024-07-19 13D/A MDWD / MediWound Ltd.
2024-02-14 13G/A WMG / Warner Music Group Corp. 376,787,388 376,240,139
2023-09-01 13D/A MDWD / MediWound Ltd.
2023-04-25 13G/A VRNA / Verona Pharma plc - Depositary Receipt (Common Stock) 32,946,296 0
2023-02-13 13D/A MDWD / MediWound Ltd.
2023-02-09 13G/A VRNA / Verona Pharma plc - Depositary Receipt (Common Stock) 51,111,648 32,946,296
2022-09-26 13D/A MDWD / MediWound Ltd.
2022-08-10 13G/A VRNA / Verona Pharma plc - Depositary Receipt (Common Stock) 44,444,448 51,111,648
2022-07-01 13D/A MDWD / MediWound Ltd.
2022-03-17 13D MDWD / MediWound Ltd. 9,429,555
2022-03-04 13D/A SNDX / Syndax Pharmaceuticals, Inc. 2,682,387 2,603,709
2022-02-14 13G/A WMG / Warner Music Group Corp. 392,676,341 376,787,388
2022-02-14 13G/A PASG / Passage Bio, Inc. 2,616,630 2,616,630
2021-05-03 13D SNDX / Syndax Pharmaceuticals, Inc. 2,138,200 2,682,387
2021-04-15 13D/A CMMB / Chemomab Therapeutics Ltd. - Depositary Receipt (Common Stock) 15,829,397 5,057,766
2021-02-16 13G/A / Pandion Therapeutics Inc 2,600,773 2,827,883
2021-02-12 13G WMG / Warner Music Group Corp. 392,676,341
2021-02-04 13G/A SNDX / Syndax Pharmaceuticals, Inc. 3,028,742 2,138,200
2020-12-21 13D/A CMMB / Chemomab Therapeutics Ltd. - Depositary Receipt (Common Stock) 15,829,397 15,829,397
2020-07-24 13G / Pandion Therapeutics Inc 2,600,773
2020-07-24 13G VRNA / Verona Pharma plc - Depositary Receipt (Common Stock) 44,444,448
2020-04-02 13D/A NTGN / Neon Therapeutics, Inc. 2,553,803 2,153,803
2020-03-31 13D/A CMMB / Chemomab Therapeutics Ltd. - Depositary Receipt (Common Stock) 15,829,397 15,829,397
2020-03-27 13D/A NTGN / Neon Therapeutics, Inc. 3,097,913 2,553,803
2020-03-12 13G PASG / Passage Bio, Inc. 2,616,630
2020-02-14 13G/A SNDX / Syndax Pharmaceuticals, Inc. 1,657,948 3,028,742
2020-01-13 13D/A CMMB / Chemomab Therapeutics Ltd. - Depositary Receipt (Common Stock) 15,829,397 15,829,397
2019-12-31 13D/A CMMB / Chemomab Therapeutics Ltd. - Depositary Receipt (Common Stock) 15,829,397 15,829,397
2019-10-09 13G SNDX / Syndax Pharmaceuticals, Inc. 1,657,948
2019-02-21 13D CMMB / Chemomab Therapeutics Ltd. - Depositary Receipt (Common Stock) 15,829,397
2019-02-14 13G/A MDWD / MediWound Ltd. 9,429,555 9,429,555
2018-07-09 13D NTGN / Neon Therapeutics, Inc. 3,097,913
2018-02-14 13G/A MDWD / MediWound Ltd. 9,389,555 9,429,555
2017-02-14 13G/A MDWD / MediWound Ltd. 9,389,555
2015-02-13 13G MDWD / MediWound Ltd. 9,789,555